|
Market Closed -
Nasdaq
21:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 834.04 USD | +0.90% |
|
+3.48% | +8.05% |
| 08-19 | Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition | MT |
| 08-19 | US FDA approves Regeneron's rare bone disorder drug | RE |
Chart: Technical Analysis
Stock exchange
Nasdaq
REGN 834.04 $
+0.90%
656M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| REGN | 834.04USD | +0.90% | 656M $ | |
CBOE
| REGN | 833.99USD | +0.94% | 16.88M $ | |
|
Boerse Muenchen
| RGO | 713.20EUR | +0.59% | 533K € | |
|
Mexican S.E.
| REGN * | 14,158.66MXN | +2.60% | 8.88M $ | |
|
Tradegate
| RGO | 714.10EUR | +0.86% | 67.84K € | |
|
Xetra
| RGO | 693.60EUR | -1.00% | 22.89K € | |
|
Borsa Italiana
| 1REGN | 687.90EUR | -0.61% | 17.2K € | |
|
London S.E.
| 0R2M | 761.97USD | +15.48% | 7.62K $ | |
|
Börse Stuttgart
| RGO | 712.50EUR | +0.61% | 1.42K € | |
|
Deutsche Boerse AG
| RGO | 702.80EUR | -1.82% | 0 € | |
|
Wiener Boerse
| REGN | 721.00EUR | +0.28% | 0 € | |
|
Lima
| REGNUS | 805.00USD | 0.00% | 0 $ | |
Sao Paulo
| REGN34 | 71.58BRL | +34.68% | 358K R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 840.84 | 840.84 | 883.2 |
| Spread/Res. | -0.81% | -0.81% | -5.57% |
| Spread/Supp. | +15.29% | +15.29% | +27.14% |
| Support | 723.41 | 723.41 | 656.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
